AI assistant
TIME OUT GROUP PLC — Director's Dealing 2020
Jun 12, 2020
7972_dirs_2020-06-12_92a2f0d7-54ee-439a-954e-5dea1ba30450.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
RNS Number : 7924P
Time Out Group plc
12 June 2020
12 June 2020
Time Out Group plc
("Time Out" or the "Company")
Director / PDMR Shareholding
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Peter Dubens
2
Reason for the notification
a)
Position/status
Non-Executive Chairman
b)
Initial notification/ Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Time Out Group plc
b)
LEI
213800BWH4OF8S4R8K10
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of Time Out Group plc
GB00BYYV0629
b)
Nature of the transaction
Purchase of Ordinary Shares in Time Out Group plc under the Open Offer
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 35 pence | 2,294,720 |
d)
Aggregated information
Aggregated volume
Price
n/a
n/a
e)
Date of the transaction
12 June 2020
f)
Place of the transaction
London Stock Exchange
| For further information, please contact: | |
| Time Out Group plc | Tel: +44 (0)207 813 3000 |
| Julio Bruno, CEO | |
| Adam Silver, CFO | |
| Steven Tredget, Investor Relations Director | |
| Liberum (Nominated Adviser and Broker) | Tel: +44 (0)203 100 2222 |
| Clayton Bush / Andrew Godber / Edward Thomas | |
| FTI Consulting LLP | Tel: +44 (0)203 727 1017 |
| Edward Bridges / Stephanie Ellis |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHFIFVRRRIFLII